MetLife

Recent news

• Company notice
  Laimu Co., Ltd.: Announcement by Laimu Co., Ltd. on the Completion of Cancellation of Stock Options for the Third Exercise Period of the 2023 Stock Option Incentive Plan, as the Exercise Conditions Were Not Met
  SZSI · 2026/5/14
• Rating change
  Inovance Technology (300124): 1H2026 performance met expectations; general automation business achieved steady growth.
  Huaxing Securities · 2026/9/9
• Company notice
  JUNSHI BIO: Overseas Regulatory Announcement – Junshi Biosciences Co., Ltd. Voluntarily Discloses that the Phase III Clinical Trial of Toripalimab in Combination with Chemotherapy for Perioperative Treatment of Patients with Resectable Stage II–III Non-Small Cell Lung Cancer Has Met Its Primary Endpoint at Final Analysis
  HKEX · 2026/5/26
• Rating change
  Piper Sandler Upgrades MetLife(MET.US) to Buy Rating, Raises Target Price to $110
  Market Newswire · 2026/9/22
• Company notice
  Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. voluntarily discloses an announcement regarding the interim analysis of its Phase III clinical trial of Yizekang® (LunKang Yilong Tuodan Kang, BL‑B01D1/iza‑bren) for the treatment of locally advanced, recurrent, or metastatic HR+HER2‑negative breast cancer, which has met the primary endpoint.
  SZSI · 2026/8/26
• Wang Jun, Deputy Commissioner of the General Administration of Customs, met with Habib Tucci, Secretary General of the International Road Transport Union (IRU), at the Administration.
  Latest · 2026/9/29
• Rating change
  Kuaishou-W (01024.HK) Q2 2026 Earnings Review: Second-quarter results met expectations; short-term headwinds persist, but the valuation is already attractive.
  Soochow Securities · 2026/8/31
• Rating change
  BYD (002594) 2026 Interim Report Commentary: Q2 results met expectations, and the trend of year-on-year and quarter-on-quarter improvement in per-vehicle profitability has been established.
  Huachuang Securities · 2026/9/1
• Company notice
  Guangting Information: Verification Opinion of the Board\'s Remuneration and Assessment Committee on Whether the Vesting Conditions for the First Vesting Period of the Initial Grant under the 2025 Restricted Stock Incentive Plan Have Been Met.
  SZSI · 2026/6/9
• Rating change
  Yanhua Shares (000792): Price and volume dynamics fully realized; dividend eligibility likely to be met within the year.
  Guosheng Securities · 2026/8/31
• Raymond James Maintains MetLife(MET.US) With Hold Rating
  Market Newswire · 2026/9/29
• Rating change
  Weichai Power (000338) Q2 2026 Earnings Review: Second-quarter results met our expectations, with the large-bore engine segment continuing to post strong growth.
  Soochow Securities · 2026/8/30
• Piper Sandler Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/9/25
• Rating change
  Morgan Stanley Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $111
  Market Newswire · 2026/8/24
• Kelun-Biotech (06990.HK): H1 2026 product sales met expectations; domestic volume growth of sac-TMT and overseas development continue to advance.
  Tianfeng Securities · 2026/9/29
• Rating change
  Zhejiang Dingli (603338): Zhejiang Dingli's results met expectations, with first-half revenue hitting a record high.
  华西证券 · 2026/8/28
• Company notice
  4: Warrior Met Coal | 4: Statement of changes in beneficial ownership of securities-Officer Gant Kelli K.
  SEC · 2026/6/5
• Rating change
  PaiNeng Technology (688063) Q2 2026 Earnings Review: Second-quarter results met our expectations, with continued strong volume growth in the light‑duty power segment.
  Dongwu Securities · 2026/8/24
• Rating change
  BYD (002594): Q2 2026 results met expectations; profit growth, after stripping out foreign-exchange effects, was particularly strong.
  Sinolink Securities · 2026/8/29
• Hutchmed (00013.HK) announced the submission of a New Drug Application (NDA) in the United States for the combination of ORPATHYS and TAGRISSO for the treatment of MET-driven EGFR-mutated lung cancer.
  Gelonghui Finance · 2026/9/29
• US August PPI month-on-month growth met expectations, while year-on-year growth slightly exceeded forecasts.
  Global Market Briefing · 9/10
• Top U.S. Stock Performers This Week | Roivant Sciences surged more than 17% this week as Phase II data for mosliciguat, developed by its subsidiary, met endpoints in treating PH-ILD; Cloudflare rose nearly 12%, indirectly benefiting as an edge computing p
  Market Newswire · 9/11
• Court Closes Light S.A. Judicial Reorganization After Plan Obligations Met
  TipRanks · 9/10
• The new iPhone launch met expectations and drove an increase in ASP, but the outlook for the iPhone remains uncertain.
  CSOP · 9/10
• Hailanxin (300065.SZ): No overseas orders for underwater data centers have met disclosure standards.
  Gelonghui Finance · 9/8

Headlines are aggregated automatically and are not independently verified or edited by our team.